These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2703008)
1. ChlVPP chemotherapy in advanced Hodgkin's disease. McKendrick JJ; Mead GM; Sweetenham J; Jones DH; Williams CJ; Ryall R; Whitehouse JM Eur J Cancer Clin Oncol; 1989 Mar; 25(3):557-61. PubMed ID: 2703008 [TBL] [Abstract][Full Text] [Related]
2. ChlVPP--an effective and well-tolerated alternative to MOPP therapy for Hodgkin's disease. Vose J; Armitage J; Weisenburger D; Moravec D; Hutchins M; Howe D; Sorensen S; Dowling M; Okerbloom J; Pevnick W Am J Clin Oncol; 1988 Aug; 11(4):423-6. PubMed ID: 3407620 [TBL] [Abstract][Full Text] [Related]
3. Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease. Ekert H; Waters KD; Smith PJ; Toogood I; Mauger D J Clin Oncol; 1988 Dec; 6(12):1845-50. PubMed ID: 3058876 [TBL] [Abstract][Full Text] [Related]
4. ChlVPP therapy for Hodgkin's disease: experience of 960 patients. The International ChlVPP Treatment Group. Ann Oncol; 1995 Feb; 6(2):167-72. PubMed ID: 7786824 [TBL] [Abstract][Full Text] [Related]
5. ChlVPP/ABV-VP16 hybrid regimen for advanced Hodgkin's disease: a study in 36 patients. Saletti P; Zucca E; Gueneau M; Peccatori F; Cavalli F; Martinelli G Leuk Lymphoma; 1999 Apr; 33(3-4):313-9. PubMed ID: 10221511 [TBL] [Abstract][Full Text] [Related]
6. ChlVPP/PABlOE and radiotherapy in advanced Hodgkin's disease. The Central Lymphoma Group. Cullen MH; Stuart NS; Woodroffe C; Murphy A; Fletcher J; Blackledge GR; Child JA; Grieve RJ; Jones EL J Clin Oncol; 1994 Apr; 12(4):779-87. PubMed ID: 7512132 [TBL] [Abstract][Full Text] [Related]
7. [Treatment outcome of advanced Hodgkin's disease based on using an alternating program ChLVPP (chlorambucil, vinblastine, procarbazine, prednisone) and ABV (doxorubicin, bleomycin, vinblastine)]. Komarnicki M; Balcerzak A; Górski P; Pawlak L; Hansz J Acta Haematol Pol; 1994; 25(4):363-8. PubMed ID: 7531381 [TBL] [Abstract][Full Text] [Related]
8. Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's disease. Druker BJ; Rosenthal DS; Canellos GP Cancer; 1989 Mar; 63(6):1060-4. PubMed ID: 2917308 [TBL] [Abstract][Full Text] [Related]
9. ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial. Hancock BW; Gregory WM; Cullen MH; Hudson GV; Burton A; Selby P; Maclennan KA; Jack A; Bessell EM; Smith P; Linch DC; ; Br J Cancer; 2001 May; 84(10):1293-300. PubMed ID: 11355937 [TBL] [Abstract][Full Text] [Related]
10. ChlVPP/ABVVP, a first line 'hybrid' combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysis. Martinelli G; Cocorocchio E; Peccatori F; Zucca E; Saletti PC; Calabrese L; Pastano R; Pruneri G; Mazzetta C; Ghielmini M; Cavalli F Br J Haematol; 2004 Jun; 125(5):584-9. PubMed ID: 15147373 [TBL] [Abstract][Full Text] [Related]
11. ChlVPP combination chemotherapy for Hodgkin's disease: long-term results. Selby P; Patel P; Milan S; Meldrum M; Mansi J; Mbidde E; Brada M; Perren T; Forgeson G; Gore M Br J Cancer; 1990 Aug; 62(2):279-85. PubMed ID: 2386744 [TBL] [Abstract][Full Text] [Related]
12. Randomized study for the treatment of advanced Hodgkin's disease: MOPP vs. LOPP. Avilés A; Díaz-Maqueo JC; García EL; Torras V; López-Vancell D Arch Invest Med (Mex); 1991; 22(1):45-50. PubMed ID: 1819976 [TBL] [Abstract][Full Text] [Related]